Dexxon Holdings Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 19,990 shares at $8.52 ($170K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.52 | 9,995 | $85K | 50.0% |
| 2 | $8.52 | 9,995 | $85K | 50.0% |
| Total | $8.52 avg | 19,990 | $170K | 100% |
| Filing → |
| UROV | BUY | 2019-05-20 | $82K | — | Filing → |
| AXON | BUY | 2019-03-19 | $20.0M | — | Filing → |
| AXON | BUY | 2018-12-20 | $10.0M | — | Filing → |